Accepted for Publication: April 9, 2015.
Published Online: June 24, 2015. doi:10.1001/jamadermatol.2015.1357.
Study concept and design: Ingen-Housz-Oro, Beylot-Barry, Brice, Bagot.
Acquisition, analysis, or interpretation of data: Laly, Ingen-Housz-Oro, Beylot-Barry, Verneuil, Adamski, Bagot.
Drafting of the manuscript: Laly, Ingen-Housz-Oro, Verneuil.
Critical revision of the manuscript for important intellectual content: Laly, Beylot-Barry, Adamski, Brice, Bagot.
Administrative, technical, or material support: Beylot-Barry.
Study supervision: Beylot-Barry, Adamski, Brice, Bagot.
Conflict of Interest Disclosures: None reported.
Additional Contributions: Amir Mirkamali, MD ( Assistance Publique–Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France), Caroline Brugières, MD (Caen University Hospital, Caen, France), Monica Dinulescu, MD (Rennes University Hospital, Rennes, France), and Anne Pham-Ledard, MD, PhD (Bordeaux University Hospital, Bordeaux, France), participated in the management of the patients and did not receive any compensation for their role.
Additional Information: Drs Ingen-Housz-Oro, Beylot-Barry, Verneuil, Adamski, and Bagot are members of the Cutaneous Lymphoma French Study Group.